Stefan Oscarson Selected Research

Stefan Oscarson Research Topics

Disease

9	Infections 10/2023 - 04/2008
7	Inflammation (Inflammations) 05/2023 - 04/2014
3	Virus Diseases (Viral Diseases) 01/2022 - 06/2019
3	Neoplasms (Cancer) 12/2021 - 07/2018
3	Urinary Tract Infections (Urinary Tract Infection) 04/2008 - 01/2005
2	Hemorrhage 01/2022 - 11/2021
2	Lung Injury 01/2022 - 11/2021
2	COVID-19 01/2022 - 11/2021
2	Pneumonia (Pneumonitis) 01/2022 - 04/2016
1	Anthrax 02/2024
1	Communicable Diseases (Infectious Diseases) 10/2023
1	Duodenal Ulcer (Curling's Ulcer) 05/2023
1	Stomach Diseases 05/2023
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Bacterial Infections (Bacterial Infection) 07/2017
1	Disease Progression 03/2017
1	Persistent Infection 03/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Asthma (Bronchial Asthma) 04/2014
1	Tuberculosis (Tuberculoses) 09/2008
1	alpha-Mannosidosis 09/2006
1	Malaria 04/2003

Drug/Important Bio-Agent (IBA)

4	Sulfhydryl Compounds (Thiols)IBA 01/2023 - 02/2015
3	OligosaccharidesIBA 02/2024 - 09/2006
3	LectinsIBA 03/2023 - 06/2019
3	MucinsIBA 01/2023 - 02/2015
3	Polysaccharides (Glycans)IBA 11/2020 - 07/2010
3	Virulence Factors (Pathogenicity Factors)IBA 04/2016 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2014
2	Conjugate VaccinesIBA 10/2023 - 10/2008
2	glucuronoxylomannanIBA 10/2023 - 11/2020
2	AntibodiesIBA 10/2023 - 05/2023
2	AntioxidantsIBA 01/2022 - 11/2021
2	Cysteamine (Mercaptamine)FDA Link 01/2022 - 11/2021
2	VaccinesIBA 12/2021 - 07/2010
2	Glycoproteins (Glycoprotein)IBA 08/2020 - 04/2016
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 08/2020 - 06/2019
2	CarbohydratesIBA 02/2015 - 07/2010
2	EpitopesIBA 04/2008 - 09/2006
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 02/2024
1	Blocking AntibodiesIBA 05/2023
1	Blood Group Antigens (Blood Groups)IBA 03/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2023
1	DisulfidesIBA 01/2023
1	Expectorants (Mucolytics)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	dornase alfa (Pulmozyme)FDA Link 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AerosolsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	GlycolipidsIBA 12/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 11/2020
1	Cell Adhesion MoleculesIBA 06/2019
1	IntegrinsIBA 06/2019
1	FluorineIBA 06/2019
1	MonosaccharidesIBA 06/2019
1	N-acetyllactosamineIBA 01/2019
1	Galectins (Galectin)IBA 01/2019
1	DisaccharidesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	AcidsIBA 03/2017
1	Catalytic AntibodiesIBA 01/2017
1	FucoseIBA 04/2016
1	GelsIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	GlycoconjugatesIBA 07/2010
1	O Antigens (O Antigen)IBA 07/2010
1	LipopolysaccharidesIBA 07/2010
1	Surface Antigens (Surface Antigen)IBA 07/2010
1	Threonine (L-Threonine)FDA Link 09/2008
1	LigandsIBA 04/2008
1	Mannose (D-Mannose)IBA 01/2005
1	Peptide Hydrolases (Proteases)FDA Link 04/2003
1	plasmepsin (plasmepsin I)IBA 04/2003

Therapy/Procedure

2	Therapeutics 12/2021 - 07/2017
2	Immunotherapy 12/2021 - 07/2018